The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation
Abstract
Background Previous studies have shown that it is feasible to withhold anticoagulation after a successful intracoronary stent procedure with a low incidence of stent thrombosis. The importance of specific antiplatelet agents when stenting is performed without anticoagulation is unknown. Methods and Results After successful intravascular ultrasound–guided stenting, 226 patients were randomly assigned to receive either aspirin therapy alone (n=103) or a combination of ticlopidine and short-term aspirin therapy (n=123). Primary angiographic and clinical end points were stent thrombosis, death, myocardial infarction, the need for postprocedure coronary artery bypass surgery or repeated angioplasty, and significant medication side effects requiring termination of the medication within the first month of a successful procedure. At 1 month, the rate of stent thrombosis was 2.9% in the aspirin only group and 0.8% in the ticlopidine-aspirin group ( P =.2). Cumulative major clinical events after successful stenting occurred in 3.9% of the patients in the aspirin group and in 0.8% in the ticlopidine-aspirin group ( P =.1). There were no medication side effects in the aspirin group; in the combined ticlopidine-aspirin group, medication side effects occurred in 3 patients ( P =.2). Conclusions At 1 month, there was no difference in the incidence of stent thrombosis or other clinical end points between the two poststent antiplatelet regimens. However, the relatively small size of the study and the low incidence of thrombosis events may have contributed to the failure to detect differences in angiographic and clinical end points between the two groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
Self-citationFischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310802 · Cited by 4,271
Self-citationThe Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
INOSITOL TRISPHOSPHATE AND DIACYLGLYCEROL: TWO INTERACTING SECOND MESSENGERS
Berridge, M. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001111 · Cited by 3,285
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
Colombo, A., Hall, P., Nakamura, S., Almagor, Y., Maiello, L., Martini, G., Gaglione, A., Goldberg, S. L., & Tobis, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1676 · Cited by 1,428
Self-citationHass, W. K., Easton, J. D., Adams, H. P., Pryse-Phillips, W., Molony, B. A., Anderson, S., Kamm, B., & for the Ticlopidine Aspirin Stroke Study Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210804 · Cited by 1,198
Cited by
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Leon, M. B., Baim, D. S., Popma, J. J., Gordon, P. C., Cutlip, D. E., Ho, K. K. L., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812033392303 · Cited by 1,815
Guidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Self-citationGrines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P., & Whitlow, P. (2007) · Circulation · doi:10.1161/circulationaha.106.180944 · Cited by 1,140
Topol, E. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85010-1 · Cited by 1,095
Bertrand, M. E., Rupprecht, H.-J., Urban, P., Gershlick, A. H., & Investigators, F. T. C. (2000) · Circulation · doi:10.1161/01.cir.102.6.624 · Cited by 1,010
Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
Cutlip, D. E., Baim, D. S., Ho, K. K. L., Popma, J. J., Lansky, A. J., Cohen, D. J., Carrozza, J. P., Chauhan, M. S., Rodriguez, O., & Kuntz, R. E. (2001) · Circulation · doi:10.1161/01.cir.103.15.1967 · Cited by 855
Price, M. J., Endemann, S., Gollapudi, R. R., Valencia, R., Stinis, C. T., Levisay, J. P., Ernst, A., Sawhney, N. S., Schatz, R. A., & Teirstein, P. S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn046 · Cited by 651
Bertrand, M. E., Legrand, V., Boland, J., Fleck, E., Bonnier, J., Emmanuelson, H., Vrolix, M., Missault, L., Chierchia, S., Casaccia, M., et al. (1998) · Circulation · doi:10.1161/01.cir.98.16.1597 · Cited by 583
Urban, P., Macaya, C., Rupprecht, H.-J., Kiemeneij, F., Emanuelsson, H., Fontanelli, A., Pieper, M., Wesseling, T., & Sagnard, L. (1998) · Circulation · doi:10.1161/01.cir.98.20.2126 · Cited by 445
Grines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O'Gara, P., & Whitlow, P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.003 · Cited by 404
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 365
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Müller, C., Büttner, H. J., Petersen, J., & Roskamm, H. (2000) · Circulation · doi:10.1161/01.cir.101.6.590 · Cited by 354
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows, T. A., & Bhatt, D. L. (2007) · Circulation Research · doi:10.1161/01.res.0000264509.36234.51 · Cited by 351
Topol, E. J., Mark, D. B., Lincoff, A. M., Cohen, E., Burton, J., Kleiman, N., Talley, D., Sapp, S., Booth, J., Cabot, C. F., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10018-7 · Cited by 324
The Antiplatelet Effects of Ticlopidine and Clopidogrel
Sharis, P. J., Cannon, C. P., & Loscalzo, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-5-199809010-00009 · Cited by 322
Cadroy, Y., Bossavy, J.-P., Thalamas, C., Sagnard, L., Sakariassen, K., & Boneu, B. (2000) · Circulation · doi:10.1161/01.cir.101.24.2823 · Cited by 266
The Road to Bioabsorbable Stents: Reaching Clinical Reality?
Erne, P., Schier, M., & Resink, T. J. (2006) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-004-0341-9 · Cited by 249
Metadata
- Authors
- Hall, P., Nakamura, S., Maiello, L., Itoh, A., Blengino, S., Martini, G., Ferraro, M., & Colombo, A.
- Venue
- Circulation
- Published
- 1996-01-15
- Volume
- 93
- Issue
- 2
- Pages
- 215-222
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2080649274
- Cited by
- 281
- References
- 15
- FWCI
- 31.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.